معرفی
Mark Grinstaff is the William Fairfield Warren Distinguished Professor at Boston University, holding primary appointments in the Department of Biomedical Engineering and the Department of Chemistry within the College of Engineering. He leads the Grinstaff Group, a multidisciplinary team focused on biomaterials, nanotechnology, and regenerative medicine. His work spans applications in cartilage repair, drug delivery, and diagnostic imaging.
- Education: B.A., Occidental College (1987); Ph.D., University of Illinois at Urbana-Champaign (1992)
His research interests include designing biodendrimers for tissue engineering, interfacial biomaterials for medical devices, and electrochemical sensors. He has pioneered contrast-enhanced computed tomography (CT) techniques for cartilage assessment and developed nanoparticle-based therapies for osteoarthritis and cancer. His lab emphasizes translational research, bridging chemistry and biomedical engineering.
Grinstaff’s recent publications highlight advancements in machine learning for osteoarthritis diagnosis, dual-contrast CT imaging, and synthetic biolubricants. His work integrates nanotechnology with clinical challenges, such as improving post-surgical outcomes and drug delivery precision.
- Awards:
- 2024 NSF Trailblazer Engineering Impact Award
- 2023 Royal Society Centenary Prize
- 2019 BMES Fellow
- 2018 Clemson Award for Applied Research
He advises students across chemistry, biomedical engineering, and materials science. His lab collaborates with the Evans Center and Materials by Design, advancing translational research in biomaterials and diagnostics. Current projects include relaxin-based treatments for fibrosis and RNA therapeutics using self-amplifying nucleotides.
Grinstaff’s affiliations include the Division of Materials Science & Engineering and the Materials by Design initiative, underscoring his role in interdisciplinary innovation at Boston University.
